Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Booz Allen Hamilton Holding Corporation (BAH) vs HCA Health Inc (HCA) Price & Performance

Booz Allen Hamilton Holding CorporationTrade
HCA Health IncTrade

Price performance (Past 24H)

Key statistics

Booz Allen Hamilton Holding Corporation vs HCA Health Inc — how do they compare? Booz Allen Hamilton Holding Corporation trades at $78.08 (market cap $9.37B), while HCA Health Inc trades at $410.01 (market cap $89.64B). The key difference: HCA Health Inc is far larger — about 9.6× Booz Allen Hamilton Holding Corporation's market cap, and Booz Allen Hamilton Holding Corporation pays the higher dividend (3.03%). Which is the better fit depends on your goals.

BAHHCA
Market Cap
$9.37B$89.64B
Sector
IndustrialsHealth
52-Week High
$111.63$545.13
52-Week Low
$59.71$361.32
Enterprise Value
$12.99B$140.18B
Dividend Yield
3.03%0.75%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Booz Allen Hamilton Holding Corporation

Booz Allen Hamilton (BAH) trades at $76.05, up 2.87% with a bullish technical signal and strong earnings beats. Recent quarters show consistent EPS outperformance, with Q2 2026 actual EPS of $1.81 beating the $1.49 estimate. The stock benefits from a discounted valuation with a P/E of 11.94 and robust cash flow growth, though revenue declined 4.2% year-over-year in Q1 2027. National security demand remains a key driver, offset by civil segment weakness.

Outlook is cautiously positive with a consensus price target of $84.67, implying 11% upside. Strengths include high ROE of 68.11% and margin expansion, but risks involve elevated debt levels and revenue volatility. Investors should weigh valuation appeal against execution risks in government contracting.

HCA Health Inc

HCA Healthcare trades at $413.36, up 1.09% on the day, with a bullish technical outlook supported by moving averages and a consensus analyst price target of $449.93. The company reported strong Q2 2026 earnings of $7.59 per share, beating estimates, and has shown consistent revenue growth, reaching $75.60 billion in 2025. Recent corporate actions include dividend payments of $0.78 per share, while news highlights executive appointments and ongoing legal investigations.

The stock presents a compelling investment case with attractive valuation multiples like a P/E of 13.86 and robust profitability, but faces risks from legal probes and high debt levels. Upside potential is supported by analyst optimism and solid operational cash flow, though investors should monitor expense pressures and regulatory developments.

Returns comparison

Trailing returns across standard periods

About Booz Allen Hamilton Holding Corporation

Booz Allen Hamilton Holding Corp is a provider of management consulting services to the U.S. government. Other services offered include technology, such as cloud computing and cybersecurity consulting, and engineering consulting. The consulting services are focused on defense, intelligence, and civil markets. In addition to the U.S. government, Booz Allen Hamilton provides its management and technology consulting services to large corporations, institutions, and nonprofit organizations. The company assists clients in long-term engagements around the globe.

Read more on BAH

About HCA Health Inc

HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.

Read more on HCA